ArticleInternational journal of women's health2025
Maternal and Neonatal Outcomes in Pregnant Women Vaccinated Against COVID-19 Compared to an Unvaccinated Group.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative immunogenicity of COVID-19 vaccination in pregnant and non-pregnant women: a real-world cohort study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Objectives: Immunizing pregnant women against COVID-19 is crucial due to their heightened risk of severe outcomes. However, data on vaccination's clinical effects during pregnancy are limited. This study evaluated maternal and neonatal outcomes in vaccinated pregnant women, stratified by vaccine doses, compared to unvaccinated controls. Patients and Methods: This retrospective cohort study analyzed pregnant women without a history of COVID-19 infection who delivered at Amir-Al-Momenin Hospital in Semnan, Iran (2020-2022). Data on demographics, obstetric history, vaccination status, maternal complications, and neonatal outcomes were extracted from hospital records. Results: The cohort included 300 vaccinated and 104 unvaccinated women with comparable baseline characteristics. Overall maternal complication rates were similar between groups (41.0% vs 44.2%). However, miscarriage was reported in 12/300 (4.0%) vaccinated women compared to 0/104 (0%) in the unvaccinated group (p=0.038). No other maternal outcomes differed significantly. Neonatal 5-minute Apgar scores were slightly lower in the vaccinated group (mean difference -0.25, 95% CI [-0.48 to -0.02]; p=0.031). Conversely, intrauterine growth restriction (IUGR) was significantly less frequent in neonates born to vaccinated mothers (2.0% vs 9.6%; Odds Ratio 0.19, 95% CI [0.07 to 0.54]; p=0.005). The number of vaccine doses received was not associated with maternal or neonatal outcomes. Conclusion: In this single-center cohort, COVID-19 vaccination during pregnancy was not associated with an overall increase in adverse maternal complications and was linked to a lower risk of neonatal IUGR. However, the findings also indicated a higher incidence of miscarriage and slightly lower 5-minute Apgar scores in the vaccinated group, which warrant further investigation. These results, while largely reassuring, highlight the need for continued surveillance and larger studies to fully characterize the safety profile of COVID-19 vaccines in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.